728 related articles for article (PubMed ID: 15879823)
1. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
[TBL] [Abstract][Full Text] [Related]
2. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status.
Jacobsen SJ; Jacobson DJ; Girman CJ; Roberts RO; Rhodes T; Guess HA; Lieber MM
J Urol; 1999 Oct; 162(4):1301-6. PubMed ID: 10492184
[TBL] [Abstract][Full Text] [Related]
3. Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting.
Keetch DW; Andriole GL; Ratliff TL; Catalona WJ
Urology; 1997 Dec; 50(6):901-5. PubMed ID: 9426721
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting.
Mochtar CA; Kiemeney LA; Laguna MP; van Riemsdijk MM; Barnett GS; Debruyne FM; de la Rosette JJ
Urology; 2005 Feb; 65(2):300-5. PubMed ID: 15708042
[TBL] [Abstract][Full Text] [Related]
5. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
Kaplan SA; Olsson CA; Te AE
J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
[TBL] [Abstract][Full Text] [Related]
6. The natural history of benign prostatic hyperplasia.
Fitzpatrick JM
BJU Int; 2006 Apr; 97 Suppl 2():3-6; discussion 21-2. PubMed ID: 16507045
[TBL] [Abstract][Full Text] [Related]
7. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002).
Vela-Navarrete R; Gonzalez-Enguita C; Garcia-Cardoso JV; Manzarbeitia F; Sarasa-Corral JL; Granizo JJ
BJU Int; 2005 Nov; 96(7):1045-8. PubMed ID: 16225526
[TBL] [Abstract][Full Text] [Related]
8. Urologic diseases in America project: benign prostatic hyperplasia.
Wei JT; Calhoun E; Jacobsen SJ
J Urol; 2005 Apr; 173(4):1256-61. PubMed ID: 15758764
[TBL] [Abstract][Full Text] [Related]
9. [Latest trends and recommendations on epidemiology, diagnosis, and treatment of benign prostatic hyperplasia (BPH)].
Gabuev A; Oelke M
Aktuelle Urol; 2011 May; 42(3):167-78. PubMed ID: 21604233
[TBL] [Abstract][Full Text] [Related]
10. Decline in the overall incidence of regional-distant prostate cancer in Olmsted County, MN, 1980-2000.
Mullan RJ; Jacobsen SJ; Bergstralh EJ; Slezak JM; Tindall DJ; Lieber MM; Roberts RO
BJU Int; 2005 May; 95(7):951-5. PubMed ID: 15839911
[TBL] [Abstract][Full Text] [Related]
11. Secular changes in radical prostatectomy utilization rates in Olmsted County, Minnesota 1980 to 1995.
Xia Z; Jacobsen SJ; Bergstralh EJ; Chute CG; Katusic SK; Lieber MM
J Urol; 1998 Mar; 159(3):904-8. PubMed ID: 9474179
[TBL] [Abstract][Full Text] [Related]
12. Incontinence related to management of benign prostatic hypertrophy.
Han E; Black LK; Lavelle JP
Am J Geriatr Pharmacother; 2007 Dec; 5(4):324-34. PubMed ID: 18179990
[TBL] [Abstract][Full Text] [Related]
13. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
Miner M; Rosenberg MT; Perelman MA
Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
[TBL] [Abstract][Full Text] [Related]
14. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.
Kitzmann AS; Pulido JS; Diehl NN; Hodge DO; Burke JP
Ophthalmology; 2008 Jan; 115(1):169-73. PubMed ID: 18166410
[TBL] [Abstract][Full Text] [Related]
15. Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota.
Roberts RO; Bergstralh EJ; Katusic SK; Lieber MM; Jacobsen SJ
J Urol; 1999 Feb; 161(2):529-33. PubMed ID: 9915441
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
17. [Diseases of the prostate in elderly patients. Benign prostate hyperplasia and prostate carcinoma].
Madersbacher S
Wien Med Wochenschr; 2001; 151(18-20):430-8. PubMed ID: 11817252
[TBL] [Abstract][Full Text] [Related]
18. Geographic variations in the use of medical and surgical therapies for benign prostatic hyperplasia.
Sung JC; Curtis LH; Schulman KA; Albala DM
J Urol; 2006 Mar; 175(3 Pt 1):1023-7. PubMed ID: 16469610
[TBL] [Abstract][Full Text] [Related]
19. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.
Yu X; Elliott SP; Wilt TJ; McBean AM
J Urol; 2008 Jul; 180(1):241-5; discussion 245. PubMed ID: 18499180
[TBL] [Abstract][Full Text] [Related]
20. New insights into the epidemiology and natural history of benign prostatic hyperplasia.
Boyle P
Prog Clin Biol Res; 1994; 386():3-18. PubMed ID: 7528398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
